European Commission approves Roche's Phesgo (fixed-dose combination of Perjeta and ...

Retrieved on: 2020-12-23 06:00:00

Tags for this article:

Clinical medicine

Drugs

Trastuzumab emtansine

DOW JONES INDUSTRIAL AVERAGE INDEX

Roche Group

Click the tags to see associated articles and topics

European Commission approves Roche's Phesgo (fixed-dose combination of Perjeta and .... View article details on HISWAI: https://www.globenewswire.com/news-release/2020/12/23/2149774/0/en/European-Commission-approves-Roche-s-Phesgo-fixed-dose-combination-of-Perjeta-and-Herceptin-for-subcutaneous-injection-for-people-with-HER2-positive-breast-cancer.html

Excerpt

Phesgo combines the same monoclonal antibodies as Perjeta and ... and trastuzumab in Phesgo is the same monoclonal antibody as in IV Herceptin.

Article found on: www.globenewswire.com

View Original Article